Effect of Anesthesia on Microelectrode Recordings During Deep Brain Stimulation Surgery: A Narrative Review.
Journal
Journal of neurosurgical anesthesiology
ISSN: 1537-1921
Titre abrégé: J Neurosurg Anesthesiol
Pays: United States
ID NLM: 8910749
Informations de publication
Date de publication:
01 Oct 2021
01 Oct 2021
Historique:
received:
25
07
2019
accepted:
04
12
2019
pubmed:
9
1
2020
medline:
15
12
2021
entrez:
9
1
2020
Statut:
ppublish
Résumé
Deep brain stimulation (DBS) is an effective surgical treatment for patients with various neurological and psychiatric disorders. Clinical improvements rely on careful patient selection and accurate electrode placement. A common method for target localization is intraoperative microelectrode recording (MER). To facilitate MER, DBS surgery is traditionally performed under local or regional anesthesia. However, sedation or general anesthesia is sometimes needed for patients who are unable to tolerate the procedure fully awake because of severe motor symptoms, psychological distress, pain, or other forms of discomfort. The effect of anesthetic drugs on MER is controversial but likely depends on the type and dose of a particular anesthetic agent, underlying disease, and surgical target. In this narrative review, we provide an overview of the current literature on the anesthetic drugs most often used for sedation and anesthesia during DBS surgery, with a focus on their effects on MERs.
Identifiants
pubmed: 31913866
pii: 00008506-202110000-00004
doi: 10.1097/ANA.0000000000000673
doi:
Substances chimiques
Anesthetics
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
300-307Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to disclose.
Références
Lozano AM, Lipsman N, Bergman H, et al. Deep brain stimulation: current challenges and future directions. Nat Rev Neurol. 2019;15:148–160.
Temel Y, Wilbrink P, Duits A, et al. Single electrode and multiple electrode guided electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. Neurosurgery. 2007;61:346–355.
Benazzouz A, Breit S, Koudsie A, et al. Intraoperative microelectrode recordings of the subthalamic nucleus in Parkinson’s disease. Mov Disord. 2002;17(suppl 3):S145–S149.
Lozano CS, Ranjan M, Boutet A, et al. Imaging alone versus microelectrode recording-guided targeting of the STN in patients with Parkinson’s disease. J Neurosurg. 2018;1:1–6.
Mulroy E, Robertson N, Macdonald L, et al. Patients’ perioperative experience of awake deep brain stimulation for Parkinson disease. World Neurosurg. 2017;105:526–528.
Xiaowu H, Xiufeng J, Xiaoping Z, et al. Risks of intracranial haemorrhage in patients with Parkinson’s disease receiving deep brain stimulation and ablation. Parkinsonism Relat Disord. 2010;16:96–100.
Centre for Evidence-based Medicine Levels of Evidence; 2009. Available at: http://www.cebm.net/index.aspx?o=1025 . Accessed July 28, 2009.
Hutchison WD, Lang AE, Dostrovsky JO, et al. Pallidal neuronal activity: implications for models of dystonia. Ann Neurol. 2003;53:480–488.
Venkatraghavan L, Rakhman E, Krishna V, et al. The effect of general anesthesia on the microelectrode recordings from pallidal neurons in patients with dystonia. J Neurosurg Anesthesiol. 2016;28:256–261.
Maltête D, Navarro S, Welter ML, et al. Subthalamic stimulation in Parkinson disease: with or without anesthesia? Arch Neurol. 2004;61:390–392.
MacIver MB, Bronte-Stewart HM, Henderson JM, et al. Human subthalamic neuron spiking exhibits subtle responses to sedatives. Anesthesiology. 2011;115:254–264.
Kim W, Song IH, Lim YH, et al. Influence of propofol and fentanyl on deep brain stimulation of the subthalamic nucleus. J Korean Med Sci. 2014;29:1278–1286.
Lee WW, Ehm G, Yang HJ, et al. Bilateral deep brain stimulation of the subthalamic nucleus under sedation with propofol and fentanyl. PloS One. 2016;11:e0152619.
Lefaucheur JP, Gurruchaga JM, Pollin B, et al. Outcome of bilateral subthalamic nucleus stimulation in treatment of Parkinson’s disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia. Eur Neurol. 2008;60:186–199.
Duque P, Mateo O, Ruiz F. Intraoperative microrecording under general anaesthesia with bispectral analysis monitoring in a case of deep brain stimulation surgery for Parkinson’s disease. Eur J Neurol. 2008;15:e76–e77.
Hertel F, Züchner M, Weimar I, Gemmar P, et al. Implantation of electrodes for deep brain stimulation of the subthalamic nucleus In advanced Parkinson’s disease with the aid of intraoperative microrecording under general anesthesia. Neurosurgery. 2006;59:E1138.
Moll CK, Payer S, Gulberti A, et al. STN stimulation in general anesthesia: evidence beyond ‘evidence-based medicine’. Acta Neurochir Suppl. 2013;117:19–25.
Raz A, Eimerl D, Zaidel A, et al. Propofol decreases neuronal population spiking activity in the subthalamic nucleus of Parkinsonian patients. Anesth Analg. 2010;111:1285–1289.
Martinez-Simon A, Alegre M, Honorato-Cia C, et al. Effect of dexmedetomidine and propofol on basal ganglia activity in Parkinson disease: a controlled clinical trial. Anesthesiology. 2017;126:1033–1042.
Sanghera MK, Grossman RG, Kalhorn CG, et al. Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy. Neurosurgery. 2003;52:1358–1370.
Lin SH, Chen TY, Lin SZ, et al. Subthalamic deep brain stimulation after anesthetic inhalation in Parkinson disease: a preliminary study. J Neurosurg. 2008;109:238–244.
Lin SH, Lai HY, Lo YC, et al. Decreased power but preserved bursting features of subthalamic neuronal signs in advanced Parkinson’s patients under controlled desflurane inhalation anesthesia. Front Neurosci. 2017;11:701.
Yamada K, Goto S, Kuratsu J, et al. Stereotactic surgery for subthalamic nucleus stimulation under general anesthesia: a retrospective evaluation of Japanese patients with Parkinson’s disease. Parkinsonism Relat Disord. 2007;13:101–107.
Alam M, Schwabe K, Lütjens G, et al. Comparative characterization of single cell activity in the globus pallidus internus of patients with dystonia or Tourette syndrome. J Neural Transm (Vienna). 2015;122:687–699.
Harries AM, Kausar J, Roberts SA, et al. Deep brain stimulation of the subthalamic nucleus for advanced Parkinson disease using general anesthesia: long-term results. J Neurosurg. 2012;116:107–113.
Castrioto A, Marmor O, Deffains M, et al. Anesthesia reduces discharge rates in the human pallidum without changing the discharge rate ratio between pallidal segments. Eur J Neurosci. 2016;44:2909–2913.
Rozet I, Muangman S, Vavilala MS, et al. Clinical experience with dexmedetomidine for implantation of deep brain stimulators in Parkinson’s disease. Anesth Analg. 2006;103:1224–1228.
Morace R, De Angelis M, Aglialoro E, et al. Sedation with α2 agonist dexmedetomidine during unilateral subthalamic nucleus deep brain stimulation: a preliminary report. World Neurosurg. 2016;89:320–328.
Elias WJ, Durieux ME, Huss D, et al. Dexmedetomidine and arousal affect subthalamic neurons. Mov Disord. 2008;23:1317–1320.
Krishna V, Elias G, Sammartino F, et al. The effect of dexmedetomidine on the firing properties of STN neurons in Parkinson’s disease. Eur J Neurosci. 2015;42:2070–2077.
Smith I, White PF, Nathanson M, et al. Propofol. An update on its clinical use. Anesthesiology. 1994;81:1005–1043.
Galvan A, Kuwajima M, Smith Y. Glutamate and GABA receptors and transporters in the basal ganglia: what does their subsynaptic localization reveal about their function. Neuroscience. 2006;143:351–375.
Franks NP. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci. 2008;9:370–386.
Goetz T, Arslan A, Wisden W, et al. GABA(A) receptors: structure and function in the basal ganglia. Prog Brain Res. 2007;160:21–41.
Alkire MT, Hudetz AG, Tononi G. Consciousness and anesthesia. Science, 322:876–880.
Hall JE, Uhrich TD, Barney JA, et al. Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg. 2000;90:699–705.
Weerink MAS, Struys MMRF, Hannivoort LN, et al. Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine. Clin Pharmacokinet. 2017;56:893–913.
Nelson LE, Lu J, Guo T, et al. The alpha2-adrenoreceptor agonist dexmedetomidine converges on an endogenuous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003;98:428–436.
Arcos D, Sierra A, Nunez A, et al. Noradrenaline increases the firing rate of a subpopulation of rat subthalamic neurones through the activation of α 1-adrenoreceptors. Neuropharmacology. 2003;45:1070–1079.
Masilamoni GJ, Groover O, Smith Y. Reduced noradrenergic innervation of ventral midbrain dopaminergic cell groups and the subthalamic nucleus in MPTP-treated parkinsonian monkeys. Neurobiol Dis. 2017;100:9–18.
Belujon P, Bezard E, Taupignon A, et al. Noradrenergic modulation of subthalamic nucleus activity: behavioural and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned rats. J Neurosci. 2007;27:9595–9606.
Delaville C, Zapata J, Cardoit L, et al. Activation of subthalamic alfa 2 noradrenergic receptors induces motor deficits as a consequence of neuronal burst firing. Neurobiol Dis. 2012;47:322–330.
Spay C, Albares M, Lio G, et al. Clonidine modulates the activity of the subthalamic-supplementary motor loop: evidence from a pharmacological study combining deep brain stimulation and electroencephalography recordings in Parkinsonian patients. J Neurochem. 2018;146:333–347.